Brain tyrosine aminotransferase: identity and possible role in the regulation of catecholamine synthesis.

Biochem J. 1982 May 15; 204(2): 622–624.

PMCID: PMC1158395

A A Badawy, D L Williams, B M Snape, and M Evans

This article has been cited by other articles in PMC.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (362K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

622

623

624

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Atack, CV. The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Br J Pharmacol. 1973 Aug;48(4):699–714. [PubMed]
Atack, CV; Magnusson, T. Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J Pharm Pharmacol. 1970 Aug;22(8):625–627. [PubMed]
Badawy, AA; Snape, BM; Evans, M. Biphasic effect of acute ethanol administration on rat liver tyrosine-2-oxoglutarate aminotransferase activity. Biochem J. 1980 Mar 15;186(3):755–761. [PubMed]
Badawy, AA; Snape, BM; Evans, M. Biphasic enhancement of rat brain tyrosine aminotransferase activity by acute ethanol administration. Subst Alcohol Actions Misuse. 1980;1(5-6):517–526. [PubMed]
BERTLER, A; CARLSSON, A; ROSENGREN, E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiol Scand. 1958 Dec 15;44(3-4):273–292. [PubMed]
Kehr, W; Carlsson, A; Lindqvist, M. A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn Schmiedebergs Arch Pharmacol. 1972;274(3):273–280. [PubMed]
Laborit, H; Thuret, F. The action of hydrocortisone on the activity of the cerebral tyrosine transaminase and on the level of cerebral norepinephrine and dopamine. Physio-pathologic deductions. Res Commun Chem Pathol Pharmacol. 1977 May;17(1):77–86. [PubMed]
NAKATA, Y; SUEMATSU, T; NAKATA, K; MATSUMOTO, K; SAKAMOTO, Y. ACTIVITIES OF VARIOUS AMINOTRANSFERASES IN TUMOR-BEARING RATS. Cancer Res. 1964 Nov;24:1689–1699. [PubMed]
Noguchi, T; Minatogawa, Y; Okuno, E; Nakatani, M; Morimoto, M. Purification and characterization of kynurenine--2-oxoglutarate aminotransferase from the liver, brain and small intestine of rats. Biochem J. 1975 Nov;151(2):399–406. [PubMed]
Noguchi, T; Nakatani, M; Minatogawa, Y; Okuno, E; Kido, R. Cerebral aromatic aminotransferase. J Neurochem. 1975 Nov;25(5):579–582. [PubMed]
Ohisalo, JJ; Andersson, BM; Viljanen, AA; Andersson, SM. Is there a brain tyrosine aminotransferase? Biochem J. 1982 May 15;204(2):621–622. [PubMed]
Snape, BM; Badawy, AA. Enhancement of rat brain tyrosine aminotransferase activity by cortisol. Biochem J. 1981 Aug 15;198(2):417–420. [PubMed]
Spano, PF; Neff, NH. Procedure for the simultaneous determination of dopamine, 3-methoxy-4-hydroxyphenylacetic acid, and 3,4-dihydroxyphenylacetic acid in brain. Anal Biochem. 1971 Jul;42(1):113–118. [PubMed]
WAALKES, TP; UDENFRIEND, S. A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med. 1957 Nov;50(5):733–736. [PubMed]